Health
China rolls out experimental Covid vaccine as it eyes global market – Financial Times
Medical experts question safety of programme before phase 3 trials are completed
Beijing is set to expand a programme that administers experimental coronavirus vaccines as Chinese developers chart a risky path to dominating global supplies.
In a surprise announcement last month, a representative from state-owned China National Biotec Group, or Sinopharm, revealed that hundreds of thousands of Chinese had already taken the company’s two leading experimental Covid-19 vaccines.
The drugs were dispensed as part of a limited use programme that began with little fanfare by the C…
Continue Reading
